Experienced medicinal drug consultations

Experienced medicinal drug consultations

Red Overlay
Medicinal and biologics
Medicinal and biologics
Red Overlay

Drug-device combination products under MDR Article 117

Introduced by the European Commission under the Medical Devices Regulation (MDR), Article 117 requires manufacturers placing drug-device combination products onto the market as an integral device and marketing them as a “medicinal product” to seek a Notified Body Opinion (NBOp). The notified body then confirms whether the device is compliant with the relevant General Safety and Performance Requirements (GSPR) and provides an NBOp Report to the manufacturer to include the Market Authorisation Application (MAA).

Visit our drug-device combination products webpage for more information on seeking an NBOp from BSI. 




BSI와 함께 최신 소식을 알아보십시오